维普期刊资源整合服务平台（V6.5）

48篇 您的检索式：作者名="Ferguson GT"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Effect of fluticasone ropionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes 显示文摘	Anzueto A Ferguson GT Feldman G	2009	COPD2009，6，5：	1
2	Prevalence and progression of osteoporosis in patients with COPD: results from the towards a revolution in COPD health study 显示文摘	Ferguson GT Calverley PM Anderson JA	2009	Chest2009，136，6：	1
3	Cardiovas- cular safety of salmeterol in COPD 显示文摘	Ferguson GT Funck-Brentano C Fischer T	2003	Chest2003，123，6：	1
4	Nasal continuous positive airway pressure in the treatment of tracheobronchomalacia 显示文摘	Ferguson GT Benoist J	1993	Am Rev Respir Dis1993，147，2：	1
5	The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD显示文摘	Dorinsky PM Reisner C Ferguson GT		0，，：	1
6	Prevalence and progression of osteoporosis in patients with COPD:results from the TOwards a Revolution in COPD Health study显示文摘	Ferguson GT Calverley PM Anderson JA	2009	Chest2009，136，6：	1
7	CO2 rebreathing during BiPAP ventilatory assistance 显示文摘	Ferguson GT Gilmartin M	1995	Am J Respir Crit Care Med1995，151，4：	1
8	显示文摘	Reisner C Ferguson GT	1999	Chest1999，115，4：	1
9	Recommendations for the management of COPD显示文摘	Ferguson GT	2000	Chest2000，117，2：	1
10	Office spirometry for lung health assessment in adults:a consensus statement from the National Lung Health Education Program显示文摘	FERGUSON GT ENRIGHT PL BUIST AS et ol	2000	Respir Care2000，45，5：	1
11	Prevalence andprogression of osteoporosis in patients with COPD ; results fromtowards a revolution in COPD health study 显示文摘	Ferguson GT Calverley PMA Anderson JA	2009	Chest2009，136，6：	1
12	Effect of fluticasone propionate/salmeterol (250/50 mg) or salmeterol (50 mg) on COPD exac- erbations显示文摘	Ferguson GT Anzueto A Fei R	2005	Respir Med2005，102，：	1
13	CO2 rebreathing during BiPAP ventilatory assistance 显示文摘	Ferguson GT Gilmartin M	1995	Am J Respir Crit Care Med1995，151，4：	1
14	Combination bmnchodilator therapy in the management of chronic obstructive pulmonary disease 显示文摘	Tashkin DP Ferguson GT	2013	Respir Res2013，14，1：	1
15	COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat:a randomized,controlled study显示文摘	Ferguson GT Ghafouri M Dai L Dunn LJ	2013	Int J Chron Obstruct Pulmon Dis2013，8，1：	1
16	Prevalence and progression of osteoporosis in patients with COPD : results from the towards a revolution in COPD health study 显示文摘	Ferguson GT Calverley PM Anderson JA	2009	Chest2009，136，6：	1
17	Improvcd exercise pcrformance following lung volumn reduction songerg for emphysema显示文摘	Feiniaidez E Zamera MR	1998	Respir Crit Remed1998，157，：	1
18	Efficacy and safety of olodaterol once daily delivered via Respimat in patients with GOLD 2-4 COPD: results from two replicate 48-week studies 显示文摘	Ferguson GT Feldman GJ Hofbauer P	2014	Int J Chron Obstruct Pulmon Dis2014，9，1：	1
19	Prevalence and progression of osteoporosis in patients with COPD : results from the Towards a Resolution in COPD Health study显示文摘	Ferguson GT Calverley PM Anderson JA	2009	Chest2009，136，：	1
20	The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in pa-tients with COPD显示文摘	Reisner C Ferguson GT	1999	Chest1999，115，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示